Accessibility Menu
 
PureTech Health Plc logo

PureTech Health Plc

(OTC) PTCHF

Current Price$1.55
Market Cap$376.76M
Since IPO (2015)-35%
5 Year-73%
1 Year-12%
1 Month-9%

PureTech Health Plc Financials at a Glance

Market Cap

$376.76M

Revenue (TTM)

$6.34M

Net Income (TTM)

$31.46M

EPS (TTM)

$0.18

P/E Ratio

8.45

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$1.55

Volume

12,700

Open

$1.55

Previous Close

$1.55

Daily Range

$1.55 - $1.55

52-Week Range

$1.27 - $1.90

PTCHF News

No articles available.

PTCHF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PureTech Health Plc

Industry

Biotechnology

CEO

Bharatt M. Chowrira, PhD

Headquarters

Boston, MA 02210, US

PTCHF Financials

Key Financial Metrics (TTM)

Gross Margin

3%

Operating Margin

-20%

Net Income Margin

9%

Return on Equity

15%

Return on Capital

-23%

Return on Assets

9%

Earnings Yield

11.83%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$376.76M

Shares Outstanding

243.07M

Volume

12.70K

Short Interest

0.00%

Avg. Volume

14.99K

Financials (TTM)

Gross Profit

$1.26M

Operating Income

$136.09M

EBITDA

$37.38M

Operating Cash Flow

$134.37M

Capital Expenditure

$11.00K

Free Cash Flow

$134.38M

Cash & ST Invst.

$367.31M

Total Debt

$22.36M

PureTech Health Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$1.85M

-41.2%

Gross Profit

$23.05M

-25997.8%

Gross Margin

-12.45%

N/A

Market Cap

$376.76M

N/A

Market Cap/Employee

$4.71M

N/A

Employees

80

N/A

Net Income

$44.60M

-78.4%

EBITDA

$46.24M

-26.5%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$300.63M

-7.9%

Accounts Receivable

$13.86M

+502.5%

Inventory

$0.00

N/A

Long Term Debt

$12.93M

-35.3%

Short Term Debt

$7.99M

+43.2%

Return on Assets

9.16%

N/A

Return on Invested Capital

-22.94%

N/A

Free Cash Flow

$45.94M

+29.5%

Operating Cash Flow

$45.94M

+29.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVCTFAvacta Group Plc
$0.83-6.02%
HUMDFHua Medicine (Shanghai) Ltd.
$0.41+0.00%
CLVLYClinuvel Pharmaceuticals Limited
$6.84+0.81%
NWBONorthwest Biotherapeutics, Inc.
$0.21-1.62%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$42.97-0.06%
ANNAAleAnna
$6.98+0.84%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.77+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.12-0.07%

Questions About PTCHF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.